Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CFRUY Stock Summary
Top 10 Correlated ETFs
CFRUY
In the News
CFRUY Financial details
Company Rating
Buy
Market Cap
80.93B
Income
2.65B
Revenue
41.16B
Book val./share
32.69
Cash/share
30.76
Dividend
0.39
Dividend %
2.98%
Employees
33.96K
Optionable
No
Shortable
Yes
Earnings
17 May 2024
P/E
2.43
Forward P/E
-
PEG
0.02
P/S
4.67
P/B
0.37
P/C
0.47
P/FCF
23.33
Quick Ratio
1.89
Current Ratio
2.47
Debt / Equity
0.67
LT Debt / Equity
0.31
-
-
EPS (TTM)
4.48
EPS next Y
-
EPS next Q
-
EPS this Y
-85.53%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-35.43%
Revenue last 5Y
5.83%
Revenue Q/Q
6.09%
EPS Q/Q
49.72%
-
-
-
-
SMA20
-11.02%
SMA50
-2.63%
SMA100
16.34%
Inst Own
0.29%
Inst Trans
0.98%
ROA
7%
ROE
16%
ROC
0.13%
Gross Margin
69%
Oper. Margin
25%
Profit Margin
19%
Payout
52%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
11.41-17.86
52W High
-15.24%
52W Low
+31%
RSI
40.34
Rel Volume
0.91
Avg Volume
574.32K
Volume
522.02K
Perf Week
-2.83%
Perf Month
-9.71%
Perf Quarter
19.19%
Perf Half Y
22.95%
-
-
-
-
Beta
1.214
-
-
Volatility
0.3%, 0.83%
Prev Close
1.77%
Price
14.41
Change
2.56%
CFRUY Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 2.55 | 2.55 | 2.31 | 3.1 | 3.36 | |
Net income per share | 0.49 | 0.17 | 0.23 | 0.37 | 0.06 | |
Operating cash flow per share | 0.37 | 0.42 | 0.56 | 0.86 | 0.76 | |
Free cash flow per share | 0.22 | 0.29 | 0.47 | 0.7 | 0.59 | |
Cash per share | 1.7 | 1.56 | 2.38 | 2.93 | 3.23 | |
Book value per share | 3 | 3.03 | 3.14 | 3.52 | 3.34 | |
Tangible book value per share | 1.34 | 1.36 | 1.51 | 1.85 | 3.05 | |
Share holders equity per share | 3 | 3.03 | 3.14 | 3.52 | 3.34 | |
Interest debt per share | 1.3 | 1.28 | 1.92 | 2.15 | 2.24 | |
Market cap | 37.2B | 27.71B | 45.92B | 64.66B | 83.28B | |
Enterprise value | 39.38B | 33.02B | 51.63B | 69.86B | 88.07B | |
P/E ratio | 13.36 | 29.7 | 35.29 | 31.18 | 266.07 | |
Price to sales ratio | 2.58 | 1.92 | 3.52 | 3.68 | 4.35 | |
POCF ratio | 17.82 | 11.55 | 14.39 | 13.28 | 19.33 | |
PFCF ratio | 30.08 | 16.76 | 17.12 | 16.37 | 24.75 | |
P/B Ratio | 2.19 | 1.62 | 2.58 | 3.25 | 4.38 | |
PTB ratio | 2.19 | 1.62 | 2.58 | 3.25 | 4.38 | |
EV to sales | 2.73 | 2.29 | 3.96 | 3.97 | 4.6 | |
Enterprise value over EBITDA | 13.32 | 10.51 | 16.97 | 12.86 | 14.23 | |
EV to operating cash flow | 18.86 | 13.76 | 16.18 | 14.35 | 20.44 | |
EV to free cash flow | 31.83 | 19.97 | 19.25 | 17.69 | 26.17 | |
Earnings yield | 0.07 | 0.03 | 0.03 | 0.03 | 0 | |
Free cash flow yield | 0.03 | 0.06 | 0.06 | 0.06 | 0.04 | |
Debt to equity | 0.42 | 0.41 | 0.6 | 0.6 | 0.66 | |
Debt to assets | 0.25 | 0.23 | 0.3 | 0.3 | 0.3 | |
Net debt to EBITDA | 0.73 | 1.69 | 1.88 | 0.96 | 0.77 | |
Current ratio | 2.74 | 2.86 | 2.61 | 2.42 | 2.47 | |
Interest coverage | 13.64 | 8.41 | 7.21 | 17.9 | 16.85 | |
Income quality | 0.73 | 2.54 | 2.47 | 1.9 | 1.14 | |
Dividend Yield | 0.03 | 0.04 | 0.01 | 0.02 | 0.02 | |
Payout ratio | 0.34 | 1.1 | 0.4 | 0.53 | 5.67 | |
Sales general and administrative to revenue | 0.19 | 0.21 | 0.19 | 0.18 | 0.19 | |
Research and developement to revenue | 0.01 | 0.01 | 0 | 0 | 0 | |
Intangibles to total assets | 0.33 | 0.31 | 0.26 | 0.24 | 0.04 | |
Capex to operating cash flow | -0.41 | -0.31 | -0.16 | -0.19 | -0.22 | |
Capex to revenue | -0.06 | -0.05 | -0.04 | -0.05 | -0.05 | |
Capex to depreciation | -1.02 | -0.5 | -0.34 | -0.72 | -0.73 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 5.77 | 3.36 | 4.04 | 5.38 | 2.03 | |
ROIC | 0.07 | 0.05 | 0.04 | 0.1 | 0.12 | |
Return on tangible assets | 0.15 | 0.04 | 0.05 | 0.07 | 0.01 | |
Graham Net | 0.39 | -0.14 | -0.1 | 0.18 | 0.2 | |
Working capital | 10.98B | 10.93B | 13.07B | 14.96B | 18.1B | |
Tangible asset value | 7.57B | 7.71B | 8.54B | 10.5B | 17.34B | |
Net current asset value | 6B | 3.25B | 3.3B | 5.29B | 8.52B | |
Invested capital | 0.42 | 0.41 | 0.6 | 0.6 | 0.66 | |
Average receivables | 1.02B | 909.5M | 893M | 1.21B | 1.47B | |
Average payables | 594.99M | 680M | 637.5M | 803.56M | 834.95M | |
Average inventory | 5.56B | 6.42B | 6.49B | 6.73B | 7.13B | |
Days sales outstanding | 26.22 | 19.82 | 28.09 | 29.59 | 28.84 | |
Days payables outstanding | 47.74 | 36.27 | 44.14 | 56.75 | 44.62 | |
Days of inventory on hand | 388.59 | 402.43 | 413.2 | 434.59 | 430.18 | |
Receivables turnover | 13.92 | 18.41 | 12.99 | 12.34 | 12.66 | |
Payables turnover | 7.65 | 10.06 | 8.27 | 6.43 | 8.18 | |
Inventory turnover | 0.94 | 0.91 | 0.88 | 0.84 | 0.85 | |
ROE | 0.16 | 0.05 | 0.07 | 0.1 | 0.02 | |
Capex per share | -0.15 | -0.13 | -0.09 | -0.16 | -0.17 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q2
Metric | History | 2021-09-30 | 2022-03-31 | 2022-09-30 | 2023-03-31 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.62 | 1.85 | 1.8 | 17.14 | 18.13 | |
Net income per share | 0.22 | 0.15 | -0.14 | 1.79 | 2.68 | |
Operating cash flow per share | 0.32 | 0.5 | 0.29 | 4.95 | 2.96 | |
Free cash flow per share | 0.27 | 0.39 | 0.22 | 3.93 | 2.27 | |
Cash per share | 2.48 | 2.93 | 2.91 | 31.78 | 30.76 | |
Book value per share | 3.23 | 3.51 | 3.2 | 32.86 | 32.69 | |
Tangible book value per share | 1.57 | 1.85 | 2.89 | 29.98 | 29.66 | |
Share holders equity per share | 3.23 | 3.51 | 3.2 | 32.86 | 32.69 | |
Interest debt per share | 2.05 | 2.13 | 2.2 | 21.84 | 22.33 | |
Market cap | 50.13B | 64.74B | 54.17B | 8.47B | 6.7B | |
Enterprise value | 56.3B | 69.94B | 59.97B | 13.25B | 12.74B | |
P/E ratio | 9.88 | 18.78 | -16.89 | 2.04 | 1.08 | |
Price to sales ratio | 5.47 | 6.16 | 5.31 | 0.85 | 0.64 | |
POCF ratio | 27.35 | 22.89 | 33.33 | 2.96 | 3.91 | |
PFCF ratio | 32.36 | 29.03 | 44.14 | 3.72 | 5.1 | |
P/B Ratio | 2.74 | 3.25 | 2.97 | 0.45 | 0.35 | |
PTB ratio | 2.74 | 3.25 | 2.97 | 0.45 | 0.35 | |
EV to sales | 6.14 | 6.65 | 5.87 | 1.34 | 1.21 | |
Enterprise value over EBITDA | 20.13 | 28.63 | 16.09 | 4.51 | 3.69 | |
EV to operating cash flow | 30.71 | 24.73 | 36.9 | 4.63 | 7.43 | |
EV to free cash flow | 36.35 | 31.36 | 48.86 | 5.83 | 9.69 | |
Earnings yield | 0.03 | 0.01 | -0.01 | 0.12 | 0.23 | |
Free cash flow yield | 0.03 | 0.03 | 0.02 | 0.27 | 0.2 | |
Debt to equity | 0.63 | 0.6 | 0.68 | 0.66 | 0.67 | |
Debt to assets | 0.31 | 0.3 | 0.31 | 0.3 | 0.31 | |
Net debt to EBITDA | 2.21 | 2.13 | 1.55 | 1.63 | 1.75 | |
Current ratio | 2.51 | 2.42 | 2.48 | 2.47 | 2.48 | |
Interest coverage | 17.69 | 13.72 | 21.42 | 13.5 | 12.86 | |
Income quality | 1.45 | 3.28 | 0.73 | 1.64 | 0.77 | |
Dividend Yield | 0.02 | 0 | 0.04 | 0 | 0.32 | |
Payout ratio | 0.84 | 0.06 | -2.44 | 0.02 | 1.37 | |
Sales general and administrative to revenue | 0.13 | 0.18 | 0.16 | 0.21 | 0.17 | |
Research and developement to revenue | 0 | 0.01 | 0 | 0.01 | 0 | |
Intangibles to total assets | 0.26 | 0.24 | 0.05 | 0.04 | 0.04 | |
Capex to operating cash flow | -0.15 | -0.21 | -0.24 | -0.21 | -0.23 | |
Capex to revenue | -0.03 | -0.06 | -0.04 | -0.06 | -0.04 | |
Capex to depreciation | -0.37 | -0.73 | -0.48 | -0.9 | -0.56 | |
Stock based compensation to revenue | 0 | 0.01 | 0 | 0.01 | 0 | |
Graham number | 4.03 | 3.46 | 3.19 | 36.38 | 44.38 | |
ROIC | 0.05 | 0.04 | 0.07 | 0.05 | 0.06 | |
Return on tangible assets | 0.05 | 0.03 | -0.02 | 0.03 | 0.04 | |
Graham Net | -0.02 | 0.15 | -0.05 | 1.99 | 1.56 | |
Working capital | 13.5B | 14.96B | 17.47B | 18.1B | 18.01B | |
Tangible asset value | 8.88B | 10.5B | 16.4B | 17.34B | 17.21B | |
Net current asset value | 4.06B | 5.29B | 7.92B | 8.52B | 8.26B | |
Invested capital | 0.63 | 0.6 | 0.68 | 0.66 | 0.67 | |
Average receivables | 1.09B | 1.2B | 1.32B | 1.46B | 1.5B | |
Average payables | 1.47B | 1.6B | 1.73B | 1.64B | 1.52B | |
Average inventory | 6.55B | 6.96B | 7.08B | 7.07B | 7.42B | |
Days sales outstanding | 11.48 | 10.47 | 12.47 | 13.73 | 12.75 | |
Days payables outstanding | 58.77 | 20.64 | 71.46 | 21.23 | 61.98 | |
Days of inventory on hand | 176.36 | 158.04 | 198.1 | 204.64 | 207.24 | |
Receivables turnover | 7.84 | 8.6 | 7.22 | 6.56 | 7.06 | |
Payables turnover | 1.53 | 4.36 | 1.26 | 4.24 | 1.45 | |
Inventory turnover | 0.51 | 0.57 | 0.45 | 0.44 | 0.43 | |
ROE | 0.07 | 0.04 | -0.04 | 0.05 | 0.08 | |
Capex per share | -0.05 | -0.11 | -0.07 | -1.02 | -0.69 |
CFRUY Frequently Asked Questions
What is Compagnie Financière Richemont SA stock symbol ?
Compagnie Financière Richemont SA is a CH stock and trading under the symbol CFRUY
What is Compagnie Financière Richemont SA stock quote today ?
Compagnie Financière Richemont SA stock price is $14.41 today.
Is Compagnie Financière Richemont SA stock public?
Yes, Compagnie Financière Richemont SA is a publicly traded company.